GPNX
NOTIFICATION PROCESSED BY IB
05/08/2020
Back to search
Official data from USPTO
ULTRASCAPE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
05/08/2020
Trademark type
Combined
Nice classes
42
Filing date
08/14/2019
Registration date
03/10/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2020
Last transaction
03/10/2020
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
24
Owner location
SG
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
IMMUNOSCAPE PTE. LTD.
Representatives
IMMUNOSCAPE PTE. LTD.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Laboratory research services in the field of biotechnology; laboratory research services in the field of immune profiling; laboratory research services in the field of vaccines; laboratory research services in the field of immunotherapy; laboratory research services in the field of immunotherapy products; laboratory research services relating to vaccines for use in the field of immunotherapy; laboratory research services in the field of vaccinesimmunotherapies for the treatment of infectious diseases and cancer; laboratory research servicesprobing for multiple T cell specificities for identification of tumor antigen-specific T cells for the treatment of cancer; laboratory research servicesprobing for multiple T cell specificities for identification of viral antigen-specific T cells in the field of infectious diseases; laboratory research servicesphenotypic and functional T cell and/or other immune cells profiling for use in the field of immunotherapy; laboratory research servicesanalysis by time-of-flight mass cytometry; laboratory research servicesanalysis by flow cytometry; laboratory research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkersdetermining the presence of biomarkers in patient samples; laboratory research servicescharacterization of biomarkersdevelopment and evaluation of biochemicalbiological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseasesdisorders and conditions associated with the immune system
Publications
History of USPTO decisions and trademark events.
15 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/22/2020
FIMP
FINAL DISPOSITION PROCESSED
04/22/2020
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
04/09/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/04/2020
PUBO
PUBLISHED FOR OPPOSITION
12/24/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/18/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/18/2019
NPUB
NOTICE OF PUBLICATION
12/04/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2019
MAFR
APPLICATION FILING RECEIPT MAILED
11/19/2019
DOCK
ASSIGNED TO EXAMINER
11/13/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/13/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/07/2019
Continuous trademark protection
Get notified about every new filing that threatens ULTRASCAPE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.